NeuroMetrix Inc
Change company Symbol lookup
Select an option...
NURO NeuroMetrix Inc
HLBZ Helbiz Inc
SRNE Sorrento Therapeutics Inc
OKTA Okta Inc
AAPL Apple Inc
CBTTF Cathedra Bitcoin Inc
IPVF InterPrivate III Financial Partners Inc
MFD Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income
SLNG Stabilis Solutions Inc
THO Thor Industries Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

NeuroMetrix, Inc. develops and commercializes health care products that utilize non-invasive neurostimulation. The Company is engaged in the designing, building and marketing of medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. It has two principal product categories, which includes point-of-care neuropathy diagnostic tests and wearable neurostimulation devices. Its products include DPNCheck, Quell and ADVANCE System. DPNCheck is a quantitative nerve conduction test that is used to evaluate peripheral neuropathies, such as Diabetic peripheral neuropathy (DPN). Quell a wearable device for symptomatic relief and management of chronic pain. ADVANCE System is a platform for the performance of nerve conduction studies. DPNCheck customers include managed care organizations, endocrinologists, podiatrists and primary care physicians. ADVANCE System customers include occupational health, primary care, internal medicine and many others.

Postmarket

Last Trade
Delayed
$4.02
0.01 (0.25%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$4.01
Day's Change
-0.05 (-1.23%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
4.22
Day's Low
3.91
Volume
(Light)
Volume:
477,196

10-day average volume:
9,533,506
477,196

NURO's position in the Health Care Equipment & Supplies industry

Industry PeersNURONTUS

Summary

Company ProfileNeuroMetrix, Inc. develops and commercializes health care products that utilize non-invasive neurostimulation. The Company is engaged in the designing, building and marketing of medical devices that...
Natus Medical Incorporated provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. It provides product solutions...
Go to NTUS summary
52-Week Change

VS. INDUSTRY
39.04%
21.81%
Market Cap

VS. INDUSTRY
$28.9M
$1.1B
Beta

VS. INDUSTRY
2.7
0.2
Dividend Yield

VS. INDUSTRY
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
--
87.69x
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$8.4M
$478.3M
Profit Margin

VS. INDUSTRY
-37.86%
2.65%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
--
-21.35%
Revenue Growth (TTM)

VS. INDUSTRY
14.11%
13.55%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.